Table 3:
Did Not Disclose | Disclosed | Relative Risk | |
---|---|---|---|
(N=252) | (N=714) | (95% CI) | |
Gender | |||
Male (N=485) | 133 (27%) | 352 (73%) | Referent |
Female (N=481) | 119 (25%) | 362 (75%) | 1.04 (0.96 – 1.12) |
Age (years): | |||
≤ 25 (N=181) | 52 (29%) | 129 (71%) | Referent |
26-44 (N=635) | 159 (25%) | 476 (75%) | 1.05 (0.95 – 1.17) |
≥45 (N=130) | 39 (30%) | 91 (70%) | 0.98 (0.85 – 1.14) |
Marital status: | |||
Single (N=37) | 14 (38%) | 23 (62%) | Referent |
Married (N=846) | 178 (21%) | 668 (79%) | 1.27 (0.99 – 1.64) |
Widow, divorced, separated (N=82) | 60 (73%) | 22 (27%) | 0.43 (0.28 – 0.67) |
Education: | |||
No School (N=239) | 69 (29%) | 170 (71%) | Referent |
Some Primary School (N=462) | 115 (25%) | 347 (75%) | 1.06 (0.96 – 1.16) |
Above Primary School (N=265) | 68 (26%) | 197 (74%) | 1.05 (0.94 – 1.16) |
Total social support score on MOS-SSS EI and TA domains combined | |||
Lowest quartile (12-20) (N=214) | 86 (40%) | 128 (60%) | Referent |
Middle two quartiles (21–47) (N=463) | 104 (22%) | 359 (78%) | 1.30 (1.15 – 1.46) |
Highest (48-60) (N=287) | 62 (22%) | 225 (78%) | 1.31 (1.16 – 1.49) |
Total score on MOS-SSS EI support domain | |||
Lowest (8-11) (N=235) | 82 (38%) | 133 (62%) | Referent |
Middle (12-31) (N=436) | 110 (24%) | 348 (76%) | 1.23 (1.09 – 1.38) |
Highest (32-40) (N=304) | 60 (21%) | 232 (79%) | 1.28 (1.14 – 1.45) |
Total score on MOS-SSS TA support domain | |||
Lowest (4-7) (N=166) | 71 (43%) | 95 (57%) | Referent |
Middle (8-16) (N=549) | 124 (23%) | 425 (77%) | 1.35 (1.18 – 1.55) |
Highest (17-20) (N=250) | 57 (23%) | 193 (77%) | 1.35 (1.16 – 1.56) |
Chronic disease symptoms | |||
1-6 symptoms (N=787) | 211 (27%) | 576 (73%) | Referent |
None (N=179) | 41 (23%) | 138 (77%) | 1.05 (0.96 – 1.15) |
WHO clinical stage | |||
Stage I or II (N=582) | 142 (24%) | 440 (76%) | Referent |
Stage III or IV (N=376) | 108 (29%) | 268 (71%) | 0.94 (0.87 – 1.02) |
CD4+ (cells/mm3) | |||
≥200 (N=483) | 128 (27%) | 355 (73%) | Referent |
<200 (N=304) | 75 (25%) | 229 (75%) | 1.02 (0.94 – 1.11) |
Able to carry out normal activities of daily living | |||
Unable to carry out (N=133) | 33 (25%) | 100 (75%) | Referent |
Able to carry out (N=831) | 218 (26%) | 613 (74%) | 0.98 (0.88-1.09) |
Responses to HIV knowledge questions | |||
<6 correct responses (N=362) | 97 (27%) | 264 (73%) | Referent |
6-8 correct responses (N=604) | 155 (26%) | 449 (74%) | 1.02 (0.94- 1.10) |
Significant depression (CES-D-10 score >10) | |||
Yes (N=465) | 128 (28%) | 337 (72%) | Referent |
No (N=501) | 124 (25%) | 377 (75%) | 1.04 (0.96–1.12) |
Length of time since first learned HIV status | |||
0–2 months (N=609) | 182 (30%) | 427 (70%) | Referent |
3–12 months (N=168) | 43 (26%) | 125 (74%) | 1.06 (0.96 – 1.18) |
>12 months (N=167) | 21 (13%) | 146 (87%) | 1.25 (1.15 – 1.35) |
Abbreviations: RR=Relative Risk, CI= Confidence intervals, MOS-SSS= Medical Outcome Study Social Support Survey, EI=emotional/informational support, TA=Tangible assistance support, CESD-10= Centre for Epidemiologic Studies Depression Scale (10 item)